Brand Name Generic Drugs Will Be Able To Save You Cash
Monday, April 26th, 2010A drug manufacturer invests money to develop new medications. This process costs time and money to do the research and clinical trials. This is a large investment and generic drugs do not have that expense attached to them. After the drug is approved, the company holds a patent on that drug.
The patent has a time limit placed on it. Patents are effective for different lengths of time in different places. When the patent is expired, the same drug in generic formula can be made by other pharmaceuticals manufacturers.
The generic must contain the active ingredients the original brand name drug has. The FDA requires this. The generic version must be nearly identical to the brand name (the active ingredients must be nearly the same).
The cost of generic drugs is much lower than the brand name for two good reasons. They are copied, which relieves them of the expense of research and clinical trials. Another reason is that more than one company can manufacture a generic version.
This creates competition between generic producers. When competition enters the picture, prices drop lower. The consumer will ordinarily prefer to buy the lower cost product as long as it has the same benefits.
It costs much less to produce generic drugs in some countries. India is the biggest producer of generic drugs. This is because people work for wages that are minimal compared to wages in the United States.
The United States President signed a new law on March 23, 2010. The FDA is required to approve all generic formulas prior to their sale. The original producer has twelve years of exclusive rights protected by patent law. After that generic versions can be produced and sold to the public. This law is named the Patient Protection and Affordable Care Act.
More generics are sold in the US than any other single country. When the patent protection expires on current brand name drugs, a large portion of them will be produced as generics. Generics medications already have approximately 78% of the US pharmaceuticals market. The implications of this fact on the market are yet to be seen.
All prescription drugs cost money to ensure safe manufacturing. One component of the cost of pharmaceuticals is the high cost of advertising on TV. It is obvious that the profit margin is higher as a result of those expenditures.
The cost is high for advertising. It does not point out to the consumers that generics can be produced in India for a portion of the cost it takes to produce them in the US. The large drug manufacturers have factories in India. These drugs are made safely at a fraction of what consumers pay for them. Yet, they imply it is unsafe to buy drugs from overseas.
To ensure safety, Indian law has enacted the death penalty for any pharmaceuticals manufacturer who knowingly makes unsafe or deliberately harmful generic drugs. This penalty covers all the producers of generics regardless of who buys them. This regulation keeps the consumers safe.